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Background: Cellular bioenergetics (cellular respiration and accompanying ATP synthesis) is a highly sensitive
biomarker of tissue injury and may be altered following infection. The status of cellular mitochondrial O2
consumption of the lung in pulmonary RSV infection is unknown.
Methods: In this study, lung fragments from RSV-infected BALB/c mice were evaluated for cellular O2 consumption,
ATP content and caspase activity. The disease was induced by intranasal inoculation with the RSV strain A2 and
lung specimens were analyzed on days 2–15 after inoculation. A phosphorescence O2 analyzer that measured
dissolved O2 concentration as a function of time was used to monitor respiration. The caspase-3 substrate analogue
N-acetyl-asp-glu-val-asp-7-amino-4-methylcoumarin (Ac-DEVD-AMC) was used to monitor intracellular caspases.
Results: O2 concentration declined linearly with time when measured in a sealed vial containing lung fragment
and glucose as a respiratory substrate, revealing its zero-order kinetics. O2 consumption was inhibited by cyanide,
confirming the oxidation occurred in the respiratory chain. Cellular respiration increased by 1.6-fold (p<0.010) and
ATP content increased by 3-fold in the first week of RSV infection. Both parameters returned to levels found in
uninfected lungs in the second week of RSV infection. Intracellular caspase activity in infected lungs was similar to
uninfected lungs throughout the course of disease.
Conclusions: Lung tissue bioenergetics is transiently enhanced in RSV infection. This energy burst, triggered by the
virus or virus-induced inflammation, is an early biomarker of the disease and may be targeted for therapy.
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CaspasesIntroduction
Human respiratory syncytial virus (RSV) is the leading
cause of bronchiolitis and pneumonia worldwide, infect-
ing nearly all children by 2 years of age [1]. Severe dis-
ease occurs in premature infants and individuals with
compromised respiratory, cardiac or immune system
[2,3]. Furthermore, exposure to RSV early in life may
predispose susceptible individuals to asthma [4].
RSV belongs to the Parmyxoviridae family of envel-
oped RNA viruses, specifically the genus Pneumovirus
[5]. Initially isolated from a chimpanzee, RSV can be
found in ruminants, such as sheep, goats and cattle; its* Correspondence: steven-varga@uiowa.edu; asouid@uaeu.ac.ae
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reproduction in any medium, provided the ormain host, however, is humans. The virus has a negative-
stranded RNA genome that codes for 10 proteins, includ-
ing 4 nucleocapsid proteins (N, P, L and M2-1; necessary
for RNA replication) and 3 envelope transmembrane pro-
teins (G, F and SH; responsible for virus attachment,
membrane fusion, entry and syncytium formation) [5].
The surface fusion protein F and the glycoprotein G serve
as the two main targets for antibodies. Variability in the G
glycoprotein is primarily responsible for the two clinical
strains of RSV, the subgroups A and B [6]. These two sub-
groups differ mainly in the extracellular domains of G and
the small hydrophobic protein SH. Based on sequence
variability of the G protein hypervariable region, the sub-
groups are further divided into clades. The matrix protein
(M) is important for viral RNA packaging, while the non-
structural proteins have regulatory activities.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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responses that includes IgM, IgA, IgG and IgE; however,
the IgG response is short lived and wanes by one year
[7]. The primary immune response is not efficient against
the initial infection, but results in an effective memory re-
sponse against reinfection. In addition, the virus generates
CD4 and CD8 T cell responses that result in classical
interferon-gamma production. Both the humoral and cell-
mediated immune responses play roles in virus clearance,
but also contribute to the immunopathology of the re-
spiratory tract.
The pathogenesis of RSV is related to its ability to
reach the lower respiratory tract, where it can cause
bronchiolitis and pneumonia [8]. The RSV strains differ
in their virulence, depending upon critical changes in
their viral genomes [9]. Overall, subgroup A causes more
illness than subgroup B [10]. In the BALB/c mouse
model of RSV infection, the virus causes lower respira-
tory tract infection, making it a good animal model to
study [8]. Of note, wild-type inbred mice are described
as semi-permissive hosts for human RSV; a very high
intranasal inoculum (105 to 107 plaque-forming units per
mouse) is usually administered to cause lower respiratory
tract disease signs and symptoms such as weight loss,
reduced activity, and ruffled fur [11]. Nevertheless, similar
to humans, constriction of the airways by mucus produc-
tion represents a hallmark of disease in mice. Other find-
ings include epithelial hypersensitivity, inflammation, and
infiltration by mononuclear cells [9,12]. Furthermore, pro-
duction of IgE antibodies and skewing of the immune re-
sponse towards higher Th-2 and lower Th-1 cytokines are
thought to contribute to asthma symptoms observed in
mice and young infants [7,9].
The molecular pathogenesis of clinically aggressive RSV
infection is poorly understood, which partially explains the
inability to control the disease at the molecular level
[13,14]. For example, information concerning RSV-induced
caspases (a series of cysteine, aspartate-specific proteases
that mediates apoptosis) in pneumatocytes is inconsistent,
and most studies are performed on cell lines. Early studies
in the lung epithelial cell line A549 identified apoptotic
mediators in response to RSV (e.g., interleukin-1 convert-
ing enzyme and CD95), but apoptosis was detected only in
~15% of infected cells [15,16]. Using the same cell line,
Bitko and Barik showed RSV-induced apoptosis was
mediated by caspase-12 (an endoplasmic reticulum stress
response caspase) [17]. Additional in vitro data implicated
RSV in inducing the anti-apoptotic factor IEX-1L, and that
normal signaling through the phosphoinositide 3-kinase
pathway blocked RSV-induced apoptosis [17,18]. The study
by Kotelkin et al. found transcriptional activations of pro-
apoptotic and anti-apoptotic factors in response to RSV in
various cell lines [19]. In another study, RSV induced
tumor necrosis factor-related apoptosis-inducing ligand(TRAIL) and its receptors and elicited apoptosis asso-
ciated with activation of caspase-8 (receptor-mediated)
and caspase-9 (mitochondrial-associated) [20].
Initiation of apoptosis requires the mitochondria to
sense the injury, resulting in leakage of cytochrome c
and other small molecular weight pro-apoptotic mole-
cules from the mitochondrial intermembrane space to
the cytosol [21]. In the cytosol, cytochrome c binds to
the apoptotic protease activating factor-1 (Apaf-1), trig-
gering the caspase cascade. Caspase activation induces
mitochondrial perturbations, which involve opening the
permeability transition pores and collapsing the electro-
chemical potential. Thus, induction of apoptosis is linked
to mitochondrial dysfunction.
Caspase-3 is also involved in proteolysis of proteins,
including poly(ADP ribose) polymerase; it cleaves at the
second aspartate in the asp-glu-val-asp sequence. Hence,
the synthetic substrate N-acetyl-asp-glu-val-asp-7-amino-4-
methylcoumarin (Ac-DEVD-AMC) can be used to monitor
intracellular caspase-3 activity. The released fluorogenic
moiety AMC can be separated on HPLC and detected with
a great accuracy [22].
The term “cellular bioenergetics” refers to the biochem-
ical processes involved in energy metabolism (energy
conversion or transformation), and the term “cellular res-
piration” (mitochondrial oxygen consumption) is used to
describe the delivery of metabolites and O2 to the mito-
chondria, oxidation of reduced metabolic fuels with the
passage of electrons to O2, and synthesis of ATP.
Measuring tissue mitochondrial O2 consumption,
using the principle that O2 quenches the phosphores-
cence of palladium II-meso-tetra-(4-sulfonatophenyl)-
tetrabenzoporphyrin, has been recently reported [22-25].
This analytical tool allows in vitro monitoring of cellular
respiration over several hours. Simultaneous determina-
tions of intracellular ATP and caspase activity, however,
are necessary, since uncoupling oxidative phosphorylation
(accelerated respiration with collapsing cellular ATP) is
common after tissue collection. Moreover, caspases are
potent inhibitors of the inner mitochondrial membrane
function. Therefore, the three parameters (respiration,
ATP content and caspase activity) are all necessary for ac-
curate assessment of lung tissue bioenergetics.
The status of lung tissue bioenergetics in RSV infec-
tion is currently unknown. It is also unclear whether RSV
infection induces pneumatocyte apoptosis and mitochon-
drial perturbation. Using assays described by us [22-26],
these unmet tasks are addressed in this study using a well-
established RSV-mouse model system [27].
Materials and methods
Reagents
Pd(II) complex of meso-tetra-(4-sulfonatophenyl)-tetra-
benzoporphyrin (Pd phosphor) was purchased from
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of caspase inhibitor I [N-benzyloxycarbonyl-val-ala-asp
(O-methyl)-fluoromethylketone; zVAD-fmk; m.w. = 467.5;
pan-caspase inhibitor] was purchased from Calbiochem
(La Jolla, CA). Ac-DEVD-AMC (N-acetyl-asp-glu-val-asp-
7-amino-4-methylcoumarin; m.w. = 675.64; caspase-3
substrate) was purchased from Axxora LLC (San Diego,
CA). Glucose (anhydrous) and remaining reagents were
purchased from Sigma-Aldrich (St. Louis, MO). HEp-2
and Vero cells were obtained from American Type Cul-
ture Collection (ATCC; Manassas, VA).
zVAD-fmk (2.14 mM) solution was made by dissolving
1.0 mg in 1.0 mL dimethyl sulfoxide and stored at −20°C.
Ac-DEVD-AMC (7.4 mM) solution was made by dissolv-
ing 5.0 mg in 1.0 mL dimethyl sulfoxide and stored at
−20°C. Phosphate-buffered saline (PBS) with glucose (137
mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM
KH2PO4 and 5 mM glucose, pH 7.4) was made fresh. Pd
phosphor solution (2.5 mg/ml = 2 mM) was prepared in
dH2O and stored in small aliquots at −20°C. NaCN (1.0
M) was prepared in dH2O; the pH was adjusted to ~7.0
with 12N HCl and stored at −20°C.
RSV
RSV strain A2 (RSV-A2) was propagated in the human
laryngeal carcinoma cell line, HEp-2 (ATCC). Briefly,
cells were grown to ~80% confluence in T-162 flasks
and infected with 0.5 ml of ~ 1–2 × 107 plaque-forming
units (PFU) per ml with gentle intermittent rocking. In-
fection was continued at 37°C in a 5% CO2 incubator for
two days until peeling of monolayer surfaces and forma-
tion of syncytia were observed. Cells were scraped from
the flask and sonicated on ice until 85 to 95% of the cells
had ruptured, releasing virus into the supernatant. The
supernatant was collected by centrifugation at 2500 rpm
for 15 min at 4°C, distributed into 500 μl aliquots, snap-
frozen in liquid nitrogen and stored at −80°C.
RNA isolation and RT-PCR
RNA was isolated from 20 to 25 mg lung tissue using 1.0
ml TRIZOL reagent (Invitrogen Life Technologies, USA)
as per manufacturer’s instruction and stored in ultrapure
water at −80°C. For reverse transcription, 5 μg of the
extracted lung RNA was DNase-treated with 3 units of
RQ1 RNase-free DNase (Promega, Madison, WI) at 37°C
for 30 min in the presence of 40 units of Recombinant
RNasin (Promega, Madison, WI). The DNased-RNA was
RT-PCR amplified with primers for glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) to confirm absence
of contaminating DNA and converted into cDNA using
300 ng of random hexamers (Metabion, Germany), 400
units of Moloney murine leukemia virus (M-MLV) reverse
transcriptase (Promega, Madison WI), and 40 units of
RNasin in a 50 μL-reaction volume at 37°C for one hr.One μL of the cDNA was used in a 25 μL reaction volume
using 20 μL of RT-PCR Supermix High Fidelity (Invitro-
gen Life Technologies, USA) with 1 μL of 25 mM MgCl2
and 50 ng each of the previously published primers RSVA
F and RSVA R [21]. The RT-PCR amplification conditions
were as follows: an initial denaturation step at 94°C for
5 min followed by 35 cycles of denaturation at 94°C,
annealing at 50°C, and extension at 72°C for 1 min each,
and a final extension step at 72°C for 7 min.
Plaque assay
Viral stocks were assayed for infectivity using a plaque
assay on Vero cells (ATCC) as described previously [27].
Briefly, near confluent Vero cells (90 to 95% cultured in
6-well plates) were infected in duplicate with 100 μl of
virus stock diluted from 10-1 to 10-9 in serum-free MEM
with intermittent gentle rocking for 90 min. Following
infection, the cells were overlaid with 4 ml of a mix of
1% agarose (SeaKem ME agarose; Cambrex) and equal
volume of 2x Eagle's Minimal Essential Medium (EMEM;
Cambrex). The incubation was continued at 37°C for 5
days before an additional overlay of 2 mL of 1% Seakem
ME agarose plus 0.01% neutral red. The plates were left
at 25°C to solidify the agarose and then incubated at
37°C for 24 hr. Plaques were counted manually on a
light box and the viral titers were expressed as plaque
forming units per lung.
Animals
Male and female BALB/c mice (4 to 10 weeks old,
weight ≈18-22 g) used in this study were purchased from
the Jackson Laboratory (Bar Harbor, ME). The mice
were housed in a room maintained at 22°C with ~60%
relative humidity in compliance with NIH guidelines
(http://grants.nih.gov/grants/olaw/references/phspol.htm).
All mice had ad libitum access to standard rodent chow
and filtered water. All protocols received approval from
the Animal Ethics Committee-UAE University-College of
Medicine and Health Sciences. At necropsy, lung speci-
mens were processed for histology, plaque assay, RT-PCR,
ATP content, O2 consumption and caspase activity.
Intranasal inoculation
BALB/c mice were anesthetized by sevoflurane inhal-
ation (100 μL per 10 g). The mice were then inoculated
intranasally with 100 μl of RSV-A2 (~ 1–2 × 106 PFU)
or mock preparation of HEp-2 culture supernatant.
Lung tissue
Lung specimens were collected on various days after in-
oculation as previously described [22-24] and immedi-
ately immersed in ice-cold Krebs-Henseleit (KH) buffer
(115 mM NaCl, 25 mM NaHCO3, 1.23 mM NaH2PO4,
1.2 mM Na2SO4, 5.9 mM KCl, 1.25 mM CaCl2, 1.18
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95% O2: 5% CO2. One specimen was immediately trans-
ferred to the O2 vial for measuring O2 consumption.
Three specimens were immediately processed for ATP
measurements. Two specimens were immediately placed
in the caspase reactions (with and without zVAD-fmk).
Specimens were also processed for histology, RT-PCR
and plaque assay.
For histology, specimens were fixed in 4% phosphate-
buffered paraformaldehyde and embedded in paraffin
wax blocks. Sections of the fixed lung fragments (5–7
μm thickness) were stained with haematoxylin and eosin
and examined under a light microscope. For O2 measure-
ments, specimens were placed in 1.0 ml of air-saturated
KH buffer containing 0.5% fat-free bovine albumin and
3 μM Pd phosphor. For viral detection, specimens were
homogenized in TRIZOL (Invitrogen, USA) and the
supernatants stored at −80°C for RNA extraction and
RT-PCR.Oxygen measurement
Phosphorescence O2 analyzer was used to monitor O2
consumption by the lung specimens [22-24]. O2 detec-
tion was performed with the aid of Pd phosphor that
had absorption maximum at 625 nm and phosphores-
cence maximum at 800 nm. Samples were exposed to
light flashes (600 per min) from a pulsed light-emitting
diode array with peak output at 625 nm (OTL630A-5-
10-66-E, Opto Technology, Inc., Wheeling, IL). Emitted
phosphorescent light was detected by a Hamamatsu
photomultiplier tube (928) after first passing it through
a wide-band interference filter centered at 800 nm. The
amplified phosphorescence decay was digitized at 1.0
MHz by a 20-MHz A/D converter (Computer Boards,
Inc., Mansfield, MA).
A program was developed using Microsoft Visual
Basic 6, Microsoft Access Database 2007, and Universal
Library components (Universal Library for Measurements
Computing Devices; http://www.mccdaq.com/daq-software/
universal-library.aspx). It allowed direct reading from the
PCI-DAS 4020/12 I/O Board (PCI-DAS 4020/12 I/O Board;
http://www.mccdaq.com/pci-data-acquisition/PCI-DAS4020-
12.aspx). The pulse detection was accomplished by search-
ing for 10 phosphorescence intensities >1.0 volt (by
default). Peak detection was accomplished by searching
for the highest 10 data points of a pulse and choosing the
data point closest to the pulse decay curve [25].
The phosphorescence decay rate (1/τ) was character-
ized by a single exponential; I = Ae-t/τ, where I = Pd
phosphor phosphorescence intensity [28]. The values of
1/τ were linear with dissolved O2: 1/τ[O2], where 1/τ =
the phosphorescence decay rate in the presence of O2,
1/τo = the phosphorescence decay rate in the absence ofO2, and kq = the second-order O2 quenching rate con-
stant in s-1 • μM-1.
Lung tissue respiration was measured at 37°C in 1-mL
sealed vials. Mixing was with the aid of parylene-coated
stirring bars. In vials sealed from air, [O2] decreased
linearly with time, indicating the kinetics of mitochon-
drial O2 consumption was zero-order. The rate of respir-
ation (k, in μM O2 min
-1) was thus the negative of the
slope d[O2]/dt. Sodium cyanide (NaCN) inhibited respir-
ation, confirming O2 was being consumed in the mito-
chondrial respiratory chain.
The calibration reaction contained PBS with 3 μM Pd
phosphor, 0.5% fat-free albumin, 50 μg/mL glucose oxi-
dase and various concentrations of β-glucose. The values
of 1/τ were linear with [β-glucose]; the value of kq was
the negative of the slope (kq = 101.1 s
-1 • μM-1). The
value of 1/τ for air-saturated solution (without glucose)
was 28,330 sec-1 (coefficient of variation, Cv = 12%) and
for O2-depleted solution (with 500 μM β-glucose, 1/τo)
2,875 s-1 (Cv = 1%). The high values of Cv for the air-
saturated solutions were due to the lower phosphores-
cence intensities with high [O2] (little light reaching the
photomultiplier tube). [O2] was calculated using, 1/τ =
1/τo + kq[O2] [28].ATP content
Lung tissue fragments were homogenized in 0.5 ml of
ice-cold 2% trichloroacetic acid for 2 min. The superna-
tants were collected by centrifugation (1000xg at 4°C for
5 min) and stored at −20°C until analysis. Immediately
before ATP measurements, the samples were neutralized
with 0.5 ml 100 mM Tris-acetate, 2 mM EDTA (final
pH, 7.75). ATP concentration was determined using the
Enliten ATP Assay System (Bioluminescence Detection
Kit, Promega, Madison, WI). Briefly, 2.5 μl of the super-
natant was added to 25 μl of the luciferin/luciferase re-
agent. The luminescence intensity was measured at 25°C
using Glomax Luminometer (Promega, Madison, WI).
The standard was linear with [ATP] (10 pM to 100 nM,
R2 >0.9999).Caspase activity
Lung specimens (~20 mg) were incubated at 37°C in KH
buffer continuously gassed with 95% O2: 5% CO2 with
and without 32 μM zVAD-fmk for 10 min. Ac-DEVD-
AMC (37 μM) was then added and the incubations con-
tinued for additional 20 min (final volume, 1.0 ml). The
tissue was disrupted by vigorous homogenization and
passages through a 27-G needle. The Ac-DEVD-AMC
cleavage reaction was quenched with tissue disruption.
The supernatant was collected by centrifugation (16,300 g
for 90 min) through a Microcentrifuge Filter (nominal
molecular weight limit = 10,000 Dalton, Sigma©),
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AMC moiety.
HPLC
The analysis was performed on a Waters 1525 reversed-
phase HPLC system (Spectra Lab Scientific Inc.,
Alexandria, VA) that consisted of a manual injector,
pump and fluorescence detector. The excitation wave-
length used was 380 nm and the emission wavelength
460 nm. Solvents A and B were HPLC-grade CH3OH:
dH2O (1:1; isocratic). The Ultrasphere IP column (4.6 ×
250 mm, Beckman) was operated at 25°C at 1.0 ml/min.
The run time was 15 min.
Statistical analysis
Data were analyzed using SPSS statistical package (ver-
sion 19). The nonparametric test (2 independent vari-
ables) Mann–Whitney was used to compare infected
and uninfected samples.
Results
RSV infection enhances lung tissue bioenergetics in BALB/c
mice. The rates of O2 consumption by infected and un-
infected lung tissue were determined immediately after
sample collection. A representative run of lung fragmentA 
Figure 1 Lung respiration in RSV-infected and uninfected BALB/c mic
(26 mg) from infected mouse on day 6. The rate of O2 consumption, k, wa
value of k after the addition of 10 μM NaCN was 0.3 (78% inhibition), confi
oxidase (catalyzes the reaction of D-glucose + O2 to D-glucono-δ-lactone +
(μM O2 min-1 mg-1) for all experiments are plotted as a function of days aft
HEp-2 culture supernatant (uninfected, U). “n” represents number of mice.(26 mg) collected on day 6 after inoculation with RSV-
A2 is shown in Figure 1A. The rate of respiration (k, the
negative of the slope of [O2] vs. t) was 1.4 μM O2 min
-1.
This rate decreased to 0.3 μM O2 min
-1 (78% inhibition)
after the addition of 10 mM sodium cyanide (a specific
poison of the cytochrome oxidase), confirming the oxi-
dation occurred mainly in the mitochondrial respiratory
chain. Glucose oxidase (catalyzes the reaction of D-
glucose + O2 to D-glucono-δ-lactone + H2O2) depleted
the remaining O2 in the solution, confirming the cyanide
inhibition of O2 consumption occurred despite available
dissolved O2 in the solution. The corrected rate of res-
piration (kc) was expressed in μM O2 min
-1 mg-1, e.g., in
Figure 1A, kc = 0.05. The values of kc were plotted in
Figure 1B as a function of days after inoculation with
RSV- A2 or mock preparation of HEp-2 culture super-
natant. The kc values for 2 ≤ t ≤ 7 days after inoculation
with mock were 0.073 ± 0.020 (n = 8) and with RSV
were 0.120 ± 0.035 (n = 8), p < 0.010. For 8 ≤ t ≤ 15
days, kc for inoculation with mock was 0.063 ± 0.038
(n = 6) and with RSV was 0.078 ± 0.041 (n = 6), p < 0.485.
Thus, lung tissue respiration was enhanced by about 65%
in the first week of RSV infection.
Intracellular lung caspase activity is not altered with
RSV infection of BALB/c mice. We next sought toB 
e. (A) A representative run of O2 consumption by lung specimen
s set as the negative of the slope of [O2] vs. t (1.4 μM O2 min
-1). The
rming the oxidation occurred mainly in the respiratory chain. Glucose
H2O2) depleted remaining O2 in the solution. (B) The values of kc
er inoculation with RSV strain A2 (infected, I) or mock preparation of




























































































































































































































Figure 2 (See legend on next page.)
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Figure 2 Lung caspase activity in RSV-infected and uninfected mice. Representative HPLC runs of the Ac-DEVD cleavage reaction by lung
specimens from infected (B and D) and uninfected (A and C) mice on days 6 (A-B) and 10 (C-D) after inoculation are shown. Briefly, BALB/c mice
were inoculated on day 0 with the RSV-A2 or the mock preparation of HEp-2 culture supernatant. Lung specimens were collected on days 6 and
10 after inoculation and immediately incubated at 37°C in 1.0 mL KH buffer (continuously gassed with 95% O2: 5% CO2) with and without 32 μM
zVAD-fmk (pan-caspase inhibitor) for 10 min. Ac-DEVD-AMC (37 μM) was then added and the incubations continued for additional 20 min. The
tissues were disrupted by vigorous homogenization and the supernatants were separated on HPLC and analyzed for the AMC peak (retention
time, Rt, ~4.8 min; the AMC moiety reflects caspase-3 activity). Ac-DEVD-AMC had a Rt of ~2.5 min. The substrate runs were without lung
specimen and showed negligible AMC peak areas. Panel E (positive control) shows increased lung tissue caspase activity in a sample from
uninfected mouse incubated in vitro in KH buffer (without oxygenation) for 0, 2 and 6 h. The AMC peak area (arbitrary units mg-1) at 0 h
(immediately post tissue collection) was 482,115, at 2 h was 3,417,616 and at 6 h was 6,456,028. Similar results were noted in 10 independent
experiments spanning the course of the disease over 15 days.
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lular caspases in the lung tissue. Figure 2 shows repre-
sentative HPLC runs of the Ac-DEVD cleavage reaction
by lung specimens from infected and uninfected mice
on days 6 and 10 after inoculation. Briefly, BALB/c mice
were inoculated on day 0 with the RSV-A2 or mock
preparation of HEp-2 culture supernatant. Lung speci-
mens were then incubated at 37°C in 1.0 ml KH buffer
(continuously gassed with 95% O2: 5% CO2) with and
without 32 μM zVAD-fmk (a pan-caspase inhibitor) for
10 min. Ac-DEVD-AMC (37 μM) was added and the
incubations continued for additional 20 min. The tissues
were disrupted by vigorous homogenization and the
supernatants were separated on HPLC and analyzed for
the AMC peak (retention time, Rt, ~4.8 min). The sub-
strate runs were exactly as above, but without lung tis-
sue; AMC peak areas for the substrate runs were
negligible (Figure 2A-D). For uninfected lungs on day 6
(Figure 2A), the AMC peak area (arbitrary units ÷ 106 ÷
specimen weight in mg) without zVAD-fmk was 0.62
and with zVAD-fmk 0.44 (29% inhibition). The corre-
sponding values for infected lungs were 1.17 (a 1.9-fold in-
crease) and 0.36 (69% inhibition), respectively (Figure 2B).
For uninfected lungs on day 10 (Figure 2C), the AMC
peak area without zVAD-fmk was 0.81 and with zVAD-
fmk 0.26 (67% inhibition). The corresponding values for
infected lungs were 0.26 and 0.23 (12% inhibition), re-
spectively (Figure 2D). Thus, the AMC moieties released
in the presence of zVAD-fmk were negligible (see panel E)
and reflected mostly non-specific hydrolysis of Ac-DEVD-
AMC. Otherwise, the sensitivity of the cleavage reaction
to zVAD-fmk typically exceeds 80%, confirming the sub-
strate was mainly hydrolyzed by caspases.
A positive control for increased lung tissue caspase ac-
tivity is shown in Figure 2E. Lung sample was collected
from an uninfected mouse and incubated in vitro in KH
buffer (without gassing with 95% O2: 5% CO2) for 0, 2
and 6 h. Under this condition, intracellular caspases are
typically induced by 2 h (personal observation). The
AMC peak area (arbitrary units ÷ 106 ÷ specimen weight
in mg) at 0 h (immediately post tissue collection) was
0.5, at 2 h was 3.4 and at 6 h was 6.5. Thus, the amountsof AMC moieties shown in panels A-D for infected and
uninfected lungs were relatively negligible. The same
results were confirmed in 10 independent experiments
spanning the course of the disease over 12 to 15 days as
shown in the examples below.
Kinetics of lung bioenergetics and caspase activity in
BALB/c mice infected with RSV-A2. Figure 3 (Panels A-
F) shows a representative experiment of lung respiration,
ATP content and caspase activity in infected and unin-
fected mice on days 2, 5, 8, 12 and 15 after inoculation.
The values of kc (Panels A, C and D), ATP (in triplicates,
Panels B, C and D) and AMC peak area (in duplicates,
Panels E and F) were plotted as a function of days after
inoculation with RSV-A2 or mock preparation of HEp-2
culture supernatant.
In infected lungs, rates of respiration and ATP con-
tents were higher on days 2 and 5 than days 8, 12 and
15 (Figure 3, Panels A, B and D). By contrast, the values
of kc and ATP in uninfected lungs were stable from days
2 to 15 (Figure 3C). The relatively low values of kc and
ATP on day 8 were confirmed in an independent experi-
ment, showing kc = 0.08 μM O2 min
-1 mg-1 for unin-
fected lung and kc = 0.06 μM O2 min
-1 mg-1 for infected
lung. Of note, the value of kc was similar in infected and
uninfected lungs on day 1 after inoculation (0.11 and
0.10, respectively). The AMC peak areas on days 2, 5, 8,
12 and 15 after inoculation with RSV-A2 (Figure 3F)
were similar to those after inoculation with mock prep-
aration of HEp-2 culture supernatant (Figure 3E).
Similar results were observed in another experiment
that measured lung respiration, ATP content and cas-
pase activity in infected and uninfected lungs on days 3,
5, 7, and 10 after inoculation (data not shown). For days
3, 5 and 7 after inoculation, the values of kc in unin-
fected lungs were 0.057 ± 0.020 μM O2 min
-1 mg-1 and
in infected lungs 0.107 ± 0.035 μM O2 min
-1 mg-1. On
day 10, the value of kc was 0.090 μM O2 min
-1 mg-1 in
both infected and uninfected lungs. Similarly, ATP con-
tents in infected lungs were higher than uninfected lungs
and caspase activity was negligible.
Histological sections from experiments on days 2–15








































































































































































































Figure 3 (See legend on next page.)
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Figure 3 Representative experiment of lung respiration, ATP content and caspase activity in RSV-infected and uninfected mice on days
2, 5, 8, 12 and 15 after inoculation. The values kc (A) and ATP (B) are plotted as a function of days after inoculation with RSV-A2 (infected, I) or
mock preparation of HEp-2 culture supernatant (uninfected, U). The values of kc and ATP are re-plotted for uninfected (C) and infected (D) mice
to further illustrate coupling of cellular respiration with ATP content. Panels E-F shows AMC peak area (reflects caspase-3 activity, done in
duplicates) in uninfected (E) and infected (F) mice (solid circles are without zVAD-fmk and open circles are with zVAD-fmk).
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inflammation present on days 8, 12 and 15 (Figure 4).
Detection of RSV-A2 in infected mice lungs. The pres-
ence of RSV in infected lungs was verified using reverse
transcriptase PCR (RT-PCR) (Figure 5). Whole cell RNA
from infected lung tissue was isolated on days 3, 5, 7
and 10 after inoculation, DNase-treated, and converted
into cDNA using the reverse transcriptase enzyme. The
resulting cDNAs were amplified using RSV-A2 specific
primers [29]. The starting RNA was free from contamin-
ating DNA, as evidenced by the lack of amplification of
the housekeeping gene glyceraldehyde 3-phosphate de-
hydrogenase (GAPDH) (data not shown). A distinct band
of the correct size (334 bp), with intensity peaking on
day 5, could be visualized that was absent in the unin-
fected lung, but present in the cDNA sample from puri-
fied RSV virions. This observation confirmed the lung
samples were infected with RSV.
Further confirmation of the presence of infectious
virus was revealed by the plaque assay [30]. Whole lung
titers (tested on days 2, 5, 8 and 10) showed a peak on
day 5 with 3 × 102 PFU/lung, while day 8 showed a titer
of 2 × 101 PFU/lung. The titers for days 2 and 10
remained below the sensitivity of the assay. These results
confirmed the RT-PCR results that the infection peaked
on day 5. Similar kinetics of infection has been observed
with RSV patient isolates tested in BALB/c mice, where
the viral load in the lung peaked on day 4 post-
intranasal inoculation of 6–8 week old mice using 105
PFU [9].
Discussion
The studied murine model shows a transient enhance-
ment of lung tissue bioenergetics (increased cellular
mitochondrial O2 consumption and ATP content) in the
first week of RSV infection (Figure 1 and 3). As previ-
ously shown, reproduction of viral particles is highly
dependent on host energy metabolism and metabolic
fuels are essential for viral survival [31]. Thus, the data
suggest that increased pneumatocyte energy conversion
(ATP production) is required early in RSV infection to
sustain active viral replication.
As shown in Figure 3, cellular ATP in infected lung
tissues increased by ~3-fold on days 2 to 5 after inocula-
tion. This finding is consistent with the study of Davis
et al. showing a 2-fold increase of nucleotide levels (ATP
and UTP) in bronchoalveolar lavage fluid of RSVinfected BALB/c mice on day 2. Moreover, inhibition of
de novo pyrimidine synthesis with leflunomide resulted
in reduction of UTP and ATP in the bronchoalveolar
lavage fluid, which reversed impaired alveolar fluid clear-
ance, edema and hypoxemia. Thus, understanding the
metabolic energy flow may be useful in combating RSV
infection [32].
Consistently, hepatitis C virus was found to utilize host
lipid metabolism for its survival in a way that promotes
liver injuries [33]. Moreover, anti-HCV therapies direc-
ted specifically at host metabolic pathways have been
successfully developed [34], which highlights the thera-
peutic potentials of targeting host metabolic pathways to
halt viral replication.
Cellular mitochondrial O2 consumption and ATP syn-
thesis are linked to the entire metabolism. Therefore,
these biomarkers are highly sensitive for detecting changes
in cellular energy processes. Both parameters are used
here to show increased energy expenditure (requirement)
in RSV infected lungs.
The virus or its associated cytokines could drive the
observed high-energy demand early in the course of RSV
infection. Since viruses typically utilize host resources, it is
likely that RSV transforms pneumatocyte metabolism
favoring viral survival. The RSV load dynamics, measured
by plaque assay in BAL samples of mice, was investigated
in one study. RSV load peaked on days 3 to 5 after inocu-
lation (representing active viral replication) and was not
detectable on day 7 and thereafter [35]. These results sug-
gest that a high-energy requirement is needed during RSV
load peak in the first week of infection. Thus, the energy
profiles shown in Figure 3 coincide with the RSV replica-
tion and returns to normal state after viral replication
ceases. Of note, lung tissue TNF-α Peribronchiolar and
peribronchial and INF-γ levels both peaked on day 5
(data not shown).
Peribronchiolar and peribronchial infiltrates were
noticeable only on days 8, 12 and 15 after inoculation
(Figure 4); that is, after the energy burst. Enhanced
(about 40%) cellular mitochondrial oxygen consumption
rate was also noted in cultured HEp-2 cells 90 min after
the addition of RSV strain A2 (data not shown).
In this model, caspase activity was not noted in the
lung tissue during the studied course of RSV infection
(Figure 2). This finding correlates with the mild disease
observed histologically (Figure 4). Virus strain, inocula-









Figure 4 Lung histology. Histological sections of mock infected and RSV-infected BALB/c mice on days 2–15 demonstrate lack of peribronchial
inflammation on days 2 and 5. There was a mild peribronchiolar and peribronchial inflammation present on days 8, 12 and 15. (Hematoxylin &
eosin, 40x).
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tributors to the observed benign disease. It remains to
be seen, however, if manipulating these variables will re-
sult in infection with increased caspase activity. Alterna-
tively, caspase induction may require a co-infection
with bacteria. Substantial caspase activity will impairmitochondrial function and deplete cellular ATP, an
event that inevitably leads to cell death. This fact
reflects the dependency of mammalian energy supply on
aerobic metabolism. Therefore, absence of apoptosis




Figure 5 Reverse transcriptase PCR (RT-PCR). Whole cell RNA
from infected lung tissue on days 3, 5, 7 and 10 after inoculation
was isolated, DNase-treated, and converted into cDNA using the
reverse transcriptase enzyme. The resulting cDNA was amplified
using RSV-A2 specific primers. The distinct band of correct size
(334 bp, with intensity peaking on day 5) is absent in the uninfected
lung, but present in infected lung and in the cDNA sample from
purified RSV virions. The same results were obtained in 2
independent experiments.
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RSV infected lungs. It is also unknown whether these
results are specific for RSV or can be seen with other
viruses. Of note, this mechanism could not be investi-
gated in vitro since the rate of respiration increased
about 4-fold in samples incubated in vitro for ≤4 h
(Additional file 1: Table S1). This finding most likely
reflected uncoupling oxidative phosphorylation as evi-
denced by the sharp decline in cellular ATP in vitro
(data not shown).
Nevertheless, the mechanism of accelerated respiration
in infected lung was further investigated as follows. First,
cellular ATP was also increased in infected lung indicat-
ing that the increased energy expenditure was not due
to uncoupling oxidative phosphorylation. Second, in
glucose-free media, cellular respiration was halted sooner
in infected lungs indicating more rapid depletion of the
endogenous metabolic fuels in RSV infected lungs. In
glucose-free media, the value of kc for uninfected lung tis-
sue was 0.05 μM O2 min
-1 mg-1 and remained the same
after the addition of 10 mM glucose at t = 50 min. The
corresponding values for the RSV infected lung were 0.05
and 0.13, respectively. Therefore, the accelerated respir-
ation in RSV infected was dependent on exogenous glu-
cose as a respiratory substrate.
It is still unclear how the RSV infection could regulate
lung tissue cellular energy conversion. Potential mechan-
isms may include increasing delivery of metabolic fuels to
host pneumatocyte, up regulating metabolic enzymes, and
preventing inhibitory (regulatory) steps in energy path-
ways. As noted above for hepatitis C, it remains to be seen
whether these biomarkers can be targeted for therapy.
Additional file
Additional file 1: Table S1. BALB/c mouse lung respiration on Days
2-15 after inoculation with RSV strain A2 or mock preparation of HEp2
culture supernatant. Respiration was measured immediately after tissuecollection (t = 0) and after in vitro incubation at 37oC in KH buffer
(gassed with 95% O2: 5% CO2) for 2 to 4 h. The increments in the rate of
respiration after in vitro incubation were due to uncoupling oxidative
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